Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-25-000120
Filing Date
2025-08-06
Accepted
2025-08-06 16:08:29
Documents
3
Period of Report
2025-08-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1754510902.html 4  
1 FORM 4 wk-form4_1754510902.xml 4 4152
2 EX-24 rogersawhney-secfilingsp.htm EX-24 5074
3 rogersawhney-secfilingsp001.jpg GRAPHIC 282324
  Complete submission text file 0001447028-25-000120.txt   399801
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK D CAMBRIDGE MA 02140
Business Address
Sawhney Roger (Reporting) CIK: 0001858748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 251189578